A Study Evaluating the Effectiveness and Safety of Pulsed Field Ablation Using the FARAPULSE™ System for Electrical Isolation of Pulmonary Veins and Superior Vena Cava

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 200 participants.

Also called NCT07162597

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07162597
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07162597. Allocation not applicable; no masking; primary purpose treatment. Start 2025-10-01 (anticipated); primary completion 2028-05-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study Evaluating the Effectiveness and Safety of Pulsed Field Ablation Using the FARAPULSE™ System for Electrical Isolation of Pulmonary Veins and Superior Vena Cava
Condition
Atrial Fibrillation (Paroxysmal)
Intervention (Device)
Pulsed Field Ablation
Lead sponsor
Shanghai Zhongshan Hospital (class: other)
Collaborator
Boston Scientific Corporation (class: industry)

Record details

Record id
cardio:ct-nct07162597
Content hash
9bfcb9095098fe6a6e0c507bb183a87bf3823f103bb0d0c106d00d1f7a6a59e1